Hyderabad: The Nation’s first Clinical Research Facility (CRF) for Stem Cells and RegSolar Industries India Limited is entering a decisive growth phase as defence manufacturing transitions from development to commercial execution.
News in Focus
Dalmia Bharat Limited delivered a resilient Q3FY26 performance, driven by healthy volume growth, disciplined cost management, and improving operating leverage.
Exide Industries is entering a decisive phase in its multi-year transformation.
The crash-game space has been moving fast lately, and Tower Rush has stepped into the spotlight with surprising confidence.
Mahindra Lifespace Developers has reached a long-awaited inflection point.
BOB Capital Markets Ltd has reiterated its BUY call on Adani Ports and Special Economic Zone Ltd, setting a target price of Rs 1,960, implying an upside of nearly 28% from current levels.
Main Regional Stories
Power Grid Corporation of India, the country’s dominant power transmission utility, is entering a structurally stronger execution phase after several quarters of muted performance.
Bajaj Finance’s Q3FY26 performance reflects a deliberate trade-off between short-term profitability and long-term balance-sheet strength.
Axis Securities has maintained its BUY recommendation on Chalet Hotels Limited with a target price of Rs 1,120, implying a 25% upside from the current market price of Rs 896.
ICICI Securities has reiterated a BUY call on Hyundai Motor India (HMIL), citing resilient execution in Q3FY26 despite near-term margin pressures linked to capacity expansion.
